• About us
• Contact

Advertisement

Organisation › Details

SomaLogic Inc. (NASDAQ: SLGC)

SomaLogic is catalyzing drug research and development and biomarker identification as a global leader in proteomics technology. With a single 55 microliter plasma or serum sample, SomaLogic can run 7,000 protein measurements, covering more than a third of the approximately 20,000 proteins in the human body. For more than 20 years SomaLogic has supported pharmaceutical companies, and academic and contract research organizations who rely on the Company’s protein detection and analysis technologies to fuel drug, disease, and treatment discoveries in such areas as oncology, diabetes, and cardiovascular, liver and metabolic diseases. *

 

	Start	2002-12-01 existent
	Group	Standard BioTools (Group)
	Industry	SomaScan® protein measurement platform using DNA measurement solution
	Industry 2	SomaScan® assay
	Person	Smythe, Roy (SomaLogic 201811– CEO before Philips + Valence Health + AVIA)
	Region	Boulder, CO
	Country	United States (USA)
	Street	2945 Wilderness Place
	City	80301 Boulder, CO
	Tel	+1-303-625-9000
		Address record changed: 2024-01-05
Basic data	Employees	n. a.
		* Document for »About Section«: Standard BioTools Inc.. (10/4/23). "Press Release: Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools". South San Francisco, CA & Boulder, CO.
		Record changed: 2024-08-13

Advertisement

More documents for Standard BioTools (Group)

• [1] Standard BioTools Inc.. (8/6/24). "Press Release: Standard BioTools to Participate in Upcoming Investor Conferences". South San Francisco, CA....
• [2] SomaLogic, Inc.. (12/22/20). "Press Release: SomaLogic Adds $81M to Series A Financing Totaling $214M". Boulder, CO....
• [3] Bayer AG. (12/21/20). "Press Release: Bayer Sells a Facility at Its Wuppertal Site to WuXi Biologics". Wuppertal & Leverkusen....
• [4] Fluidigm Corporation. (5/7/20). "Press Release: Fluidigm Announces First Quarter 2020 Financial Results". South San Francisco, CA....
• [5] Fluidigm Corporation. (5/7/20). "Press Release: Fluidigm Expands Accessibility of Mass Cytometry and Imaging Mass Cytometry Technology with New Therapeutic Insights Services". South San Francisco, CA....
• [6] Fluidigm Corporation. (3/3/20). "Press Release: Fluidigm and Next Gen Diagnostics Enter into Agreement to Improve the Efficiency of Pathogen Sample Preparation for Microbial Whole Genome Sequencing". South San Francisco, CA & Hinxton....
• [7] Fluidigm Corporation. (2/26/20). "Press Release: Fluidigm Completes Acquisition of InstruNor AS". South San Francisco, CA....
• [8] Fluidigm Corporation. (2/10/20). "Press Release: Fluidigm CyTOF Technology Selected by Covance to Develop Highly Multiplexed Human Immune Profiling Services". South San Francisco, CA....
• [9] Fluidigm Corporation. (2/10/20). "Press Release: Fluidigm Announces Fourth Quarter and Full Year 2019 Financial Results". South San Francisco, CA....
• [10] MorphoSys AG. (11/20/19). "Press Release: Markus Enzelberger, Chief Scientific Officer of MorphoSys, Announces His Departure". Planegg....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.